nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—breast cancer—Betamethasone—multiple sclerosis	0.211	0.5	CpDpCtD
Testosterone Propionate—breast cancer—Dexamethasone—multiple sclerosis	0.211	0.5	CpDpCtD
Testosterone Propionate—CYP17A1—Dexamethasone—multiple sclerosis	0.0884	1	CbGbCtD
Testosterone Propionate—Potassium Canrenoate—Prednisone—multiple sclerosis	0.0134	0.0335	CrCrCtD
Testosterone Propionate—Potassium Canrenoate—Prednisolone—multiple sclerosis	0.0131	0.0327	CrCrCtD
Testosterone Propionate—Medrysone—Methylprednisolone—multiple sclerosis	0.0124	0.031	CrCrCtD
Testosterone Propionate—Medroxyprogesterone Acetate—Methylprednisolone—multiple sclerosis	0.0119	0.0298	CrCrCtD
Testosterone Propionate—Danazol—Prednisone—multiple sclerosis	0.0113	0.0283	CrCrCtD
Testosterone Propionate—Medrysone—Prednisolone—multiple sclerosis	0.011	0.0276	CrCrCtD
Testosterone Propionate—Hydrocortamate—Methylprednisolone—multiple sclerosis	0.0108	0.0269	CrCrCtD
Testosterone Propionate—Cortisone acetate—Methylprednisolone—multiple sclerosis	0.0104	0.0261	CrCrCtD
Testosterone Propionate—Testolactone—Methylprednisolone—multiple sclerosis	0.0101	0.0253	CrCrCtD
Testosterone Propionate—Testolactone—Dexamethasone—multiple sclerosis	0.00998	0.0249	CrCrCtD
Testosterone Propionate—Testolactone—Betamethasone—multiple sclerosis	0.00998	0.0249	CrCrCtD
Testosterone Propionate—Hydrocortamate—Prednisone—multiple sclerosis	0.00984	0.0246	CrCrCtD
Testosterone Propionate—Testolactone—Triamcinolone—multiple sclerosis	0.00975	0.0244	CrCrCtD
Testosterone Propionate—Hydrocortamate—Prednisolone—multiple sclerosis	0.0096	0.024	CrCrCtD
Testosterone Propionate—Cortisone acetate—Prednisone—multiple sclerosis	0.00954	0.0238	CrCrCtD
Testosterone Propionate—Cortisone acetate—Prednisolone—multiple sclerosis	0.00931	0.0233	CrCrCtD
Testosterone Propionate—Testolactone—Prednisone—multiple sclerosis	0.00925	0.0231	CrCrCtD
Testosterone Propionate—Fluoxymesterone—Betamethasone—multiple sclerosis	0.00917	0.0229	CrCrCtD
Testosterone Propionate—Fluoxymesterone—Dexamethasone—multiple sclerosis	0.00917	0.0229	CrCrCtD
Testosterone Propionate—Fludrocortisone—Methylprednisolone—multiple sclerosis	0.00908	0.0227	CrCrCtD
Testosterone Propionate—Testolactone—Prednisolone—multiple sclerosis	0.00903	0.0226	CrCrCtD
Testosterone Propionate—Fluoxymesterone—Triamcinolone—multiple sclerosis	0.00896	0.0224	CrCrCtD
Testosterone Propionate—Fludrocortisone—Betamethasone—multiple sclerosis	0.00893	0.0223	CrCrCtD
Testosterone Propionate—Fludrocortisone—Dexamethasone—multiple sclerosis	0.00893	0.0223	CrCrCtD
Testosterone Propionate—Fludrocortisone—Triamcinolone—multiple sclerosis	0.00873	0.0218	CrCrCtD
Testosterone Propionate—Loteprednol—Methylprednisolone—multiple sclerosis	0.00843	0.0211	CrCrCtD
Testosterone Propionate—Fluoxymesterone—Prednisolone—multiple sclerosis	0.0083	0.0207	CrCrCtD
Testosterone Propionate—Loteprednol—Dexamethasone—multiple sclerosis	0.0083	0.0207	CrCrCtD
Testosterone Propionate—Loteprednol—Betamethasone—multiple sclerosis	0.0083	0.0207	CrCrCtD
Testosterone Propionate—Fludrocortisone—Prednisone—multiple sclerosis	0.00828	0.0207	CrCrCtD
Testosterone Propionate—Loteprednol—Triamcinolone—multiple sclerosis	0.00811	0.0203	CrCrCtD
Testosterone Propionate—Progesterone—Prednisolone—multiple sclerosis	0.00809	0.0202	CrCrCtD
Testosterone Propionate—Fludrocortisone—Prednisolone—multiple sclerosis	0.00809	0.0202	CrCrCtD
Testosterone Propionate—Methyltestosterone—Prednisone—multiple sclerosis	0.00808	0.0202	CrCrCtD
Testosterone Propionate—Methyltestosterone—Prednisolone—multiple sclerosis	0.00788	0.0197	CrCrCtD
Testosterone Propionate—Loteprednol—Prednisone—multiple sclerosis	0.00769	0.0192	CrCrCtD
Testosterone Propionate—Loteprednol—Prednisolone—multiple sclerosis	0.00751	0.0188	CrCrCtD
Testosterone Propionate—Hydrocortisone—Methylprednisolone—multiple sclerosis	0.0074	0.0185	CrCrCtD
Testosterone Propionate—Hydrocortisone—Betamethasone—multiple sclerosis	0.00729	0.0182	CrCrCtD
Testosterone Propionate—Hydrocortisone—Dexamethasone—multiple sclerosis	0.00729	0.0182	CrCrCtD
Testosterone Propionate—Hydrocortisone—Triamcinolone—multiple sclerosis	0.00712	0.0178	CrCrCtD
Testosterone Propionate—Testosterone—Prednisolone—multiple sclerosis	0.00702	0.0175	CrCrCtD
Testosterone Propionate—Hydrocortisone—Prednisone—multiple sclerosis	0.00676	0.0169	CrCrCtD
Testosterone Propionate—Hydrocortisone—Prednisolone—multiple sclerosis	0.00659	0.0165	CrCrCtD
Testosterone Propionate—COMT—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—multiple sclerosis	0.00155	0.0709	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.0011	0.0502	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.0011	0.0502	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Glucocorticoid biosynthesis—POMC—multiple sclerosis	0.000769	0.0351	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000682	0.0311	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000682	0.0311	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000673	0.0307	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000673	0.0307	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Androgen biosynthesis—POMC—multiple sclerosis	0.000596	0.0272	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Irinotecan Pathway—BCHE—multiple sclerosis	0.000595	0.0272	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000553	0.0252	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000553	0.0252	CbGpPWpGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—HNRNPA1—multiple sclerosis	0.00051	0.0233	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000458	0.0209	CbGpPWpGaD
Testosterone Propionate—Dydrogesterone—PGR—multiple sclerosis	0.000435	0.143	CrCbGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—ZMIZ1—multiple sclerosis	0.000403	0.0184	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000366	0.0167	CbGpPWpGaD
Testosterone Propionate—Ethynodiol—PGR—multiple sclerosis	0.000359	0.118	CrCbGaD
Testosterone Propionate—CYP17A1—Endogenous sterols—POMC—multiple sclerosis	0.00033	0.0151	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptors—PGR—multiple sclerosis	0.000324	0.0148	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—KCNA3—multiple sclerosis	0.000323	0.0148	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—CYP24A1—multiple sclerosis	0.000307	0.014	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—CYP27B1—multiple sclerosis	0.000307	0.014	CbGpPWpGaD
Testosterone Propionate—Norgestimate—PGR—multiple sclerosis	0.000305	0.1	CrCbGaD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000303	0.0138	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000303	0.0138	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—ZMIZ1—multiple sclerosis	0.000298	0.0136	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000294	0.0134	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000294	0.0134	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00029	0.0132	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00029	0.0132	CbGpPWpGaD
Testosterone Propionate—Danazol—CCL2—multiple sclerosis	0.000279	0.0918	CrCbGaD
Testosterone Propionate—Megestrol acetate—PGR—multiple sclerosis	0.000262	0.0861	CrCbGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.000256	0.0117	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.000248	0.0113	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.00023	0.0105	CbGpPWpGaD
Testosterone Propionate—Drospirenone—PGR—multiple sclerosis	0.000229	0.0752	CrCbGaD
Testosterone Propionate—AR—Nuclear Receptors—VDR—multiple sclerosis	0.000226	0.0103	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.000195	0.00891	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.00019	0.00868	CbGpPWpGaD
Testosterone Propionate—Levonorgestrel—PGR—multiple sclerosis	0.000187	0.0614	CrCbGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000184	0.00839	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000184	0.00839	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000181	0.00827	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000181	0.00827	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000179	0.00817	CbGpPWpGaD
Testosterone Propionate—Danazol—PGR—multiple sclerosis	0.00017	0.0559	CrCbGaD
Testosterone Propionate—Spironolactone—PGR—multiple sclerosis	0.000163	0.0535	CrCbGaD
Testosterone Propionate—Drospirenone—BCHE—multiple sclerosis	0.000157	0.0515	CrCbGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	0.000156	0.00711	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000153	0.007	CbGpPWpGaD
Testosterone Propionate—Medroxyprogesterone Acetate—PGR—multiple sclerosis	0.000153	0.0502	CrCbGaD
Testosterone Propionate—Norethindrone—PGR—multiple sclerosis	0.000151	0.0497	CrCbGaD
Testosterone Propionate—AR—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000147	0.00669	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000144	0.00658	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000144	0.00658	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000124	0.00568	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	0.000124	0.00564	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	0.00012	0.00549	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000118	0.0054	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000113	0.00515	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000113	0.00515	CbGpPWpGaD
Testosterone Propionate—Rash—Cladribine—multiple sclerosis	0.000108	0.00168	CcSEcCtD
Testosterone Propionate—Dermatitis—Cladribine—multiple sclerosis	0.000108	0.00168	CcSEcCtD
Testosterone Propionate—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000108	0.00168	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000108	0.00168	CcSEcCtD
Testosterone Propionate—Weight increased—Prednisone—multiple sclerosis	0.000107	0.00168	CcSEcCtD
Testosterone Propionate—Headache—Cladribine—multiple sclerosis	0.000107	0.00167	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—CD4—multiple sclerosis	0.000106	0.00482	CbGpPWpGaD
Testosterone Propionate—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000105	0.00164	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000105	0.00164	CcSEcCtD
Testosterone Propionate—Mental disorder—Methylprednisolone—multiple sclerosis	0.000105	0.00163	CcSEcCtD
Testosterone Propionate—Malnutrition—Methylprednisolone—multiple sclerosis	0.000104	0.00162	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—MAPK1—multiple sclerosis	0.000104	0.00473	CbGpPWpGaD
Testosterone Propionate—Breast disorder—Methotrexate—multiple sclerosis	0.000103	0.00161	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Azathioprine—multiple sclerosis	0.000103	0.0016	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000103	0.0016	CcSEcCtD
Testosterone Propionate—Malaise—Prednisolone—multiple sclerosis	0.000102	0.00159	CcSEcCtD
Testosterone Propionate—Nausea—Cladribine—multiple sclerosis	0.000102	0.00159	CcSEcCtD
Testosterone Propionate—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000101	0.00158	CcSEcCtD
Testosterone Propionate—Dyspnoea—Mitoxantrone—multiple sclerosis	0.0001	0.00157	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	9.88e-05	0.00451	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Betamethasone—multiple sclerosis	9.85e-05	0.00153	CcSEcCtD
Testosterone Propionate—Angiopathy—Dexamethasone—multiple sclerosis	9.85e-05	0.00153	CcSEcCtD
Testosterone Propionate—Hypertension—Prednisolone—multiple sclerosis	9.78e-05	0.00152	CcSEcCtD
Testosterone Propionate—Fatigue—Mitoxantrone—multiple sclerosis	9.71e-05	0.00151	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Triamcinolone—multiple sclerosis	9.66e-05	0.00151	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Methylprednisolone—multiple sclerosis	9.64e-05	0.0015	CcSEcCtD
Testosterone Propionate—Pain—Mitoxantrone—multiple sclerosis	9.63e-05	0.0015	CcSEcCtD
Testosterone Propionate—Alopecia—Betamethasone—multiple sclerosis	9.59e-05	0.00149	CcSEcCtD
Testosterone Propionate—Alopecia—Dexamethasone—multiple sclerosis	9.59e-05	0.00149	CcSEcCtD
Testosterone Propionate—Diarrhoea—Azathioprine—multiple sclerosis	9.53e-05	0.00149	CcSEcCtD
Testosterone Propionate—Discomfort—Prednisolone—multiple sclerosis	9.53e-05	0.00148	CcSEcCtD
Testosterone Propionate—Haemoglobin—Prednisone—multiple sclerosis	9.5e-05	0.00148	CcSEcCtD
Testosterone Propionate—Haemorrhage—Prednisone—multiple sclerosis	9.45e-05	0.00147	CcSEcCtD
Testosterone Propionate—Malaise—Triamcinolone—multiple sclerosis	9.39e-05	0.00146	CcSEcCtD
Testosterone Propionate—Malaise—Methylprednisolone—multiple sclerosis	9.37e-05	0.00146	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Prednisone—multiple sclerosis	9.29e-05	0.00145	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Mitoxantrone—multiple sclerosis	9.28e-05	0.00145	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Prednisolone—multiple sclerosis	9.24e-05	0.00144	CcSEcCtD
Testosterone Propionate—Oedema—Prednisolone—multiple sclerosis	9.24e-05	0.00144	CcSEcCtD
Testosterone Propionate—Dysuria—Methotrexate—multiple sclerosis	9.23e-05	0.00144	CcSEcCtD
Testosterone Propionate—Dizziness—Azathioprine—multiple sclerosis	9.22e-05	0.00144	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	9.21e-05	0.00144	CcSEcCtD
Testosterone Propionate—Erectile dysfunction—Methotrexate—multiple sclerosis	9.09e-05	0.00142	CcSEcCtD
Testosterone Propionate—COMT—Neuronal System—BCHE—multiple sclerosis	9.07e-05	0.00414	CbGpPWpGaD
Testosterone Propionate—Hypertension—Triamcinolone—multiple sclerosis	8.99e-05	0.0014	CcSEcCtD
Testosterone Propionate—Hypertension—Methylprednisolone—multiple sclerosis	8.97e-05	0.0014	CcSEcCtD
Testosterone Propionate—Urticaria—Mitoxantrone—multiple sclerosis	8.95e-05	0.00139	CcSEcCtD
Testosterone Propionate—Abdominal pain—Mitoxantrone—multiple sclerosis	8.91e-05	0.00139	CcSEcCtD
Testosterone Propionate—Myalgia—Triamcinolone—multiple sclerosis	8.87e-05	0.00138	CcSEcCtD
Testosterone Propionate—Vomiting—Azathioprine—multiple sclerosis	8.86e-05	0.00138	CcSEcCtD
Testosterone Propionate—Arthralgia—Methylprednisolone—multiple sclerosis	8.85e-05	0.00138	CcSEcCtD
Testosterone Propionate—Myalgia—Methylprednisolone—multiple sclerosis	8.85e-05	0.00138	CcSEcCtD
Testosterone Propionate—Anxiety—Methylprednisolone—multiple sclerosis	8.82e-05	0.00137	CcSEcCtD
Testosterone Propionate—Progesterone—PGR—multiple sclerosis	8.81e-05	0.029	CrCbGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	8.81e-05	0.00402	CbGpPWpGaD
Testosterone Propionate—Rash—Azathioprine—multiple sclerosis	8.79e-05	0.00137	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	8.79e-05	0.00137	CcSEcCtD
Testosterone Propionate—Dermatitis—Azathioprine—multiple sclerosis	8.78e-05	0.00137	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	8.78e-05	0.00401	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Betamethasone—multiple sclerosis	8.77e-05	0.00137	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Dexamethasone—multiple sclerosis	8.77e-05	0.00137	CcSEcCtD
Testosterone Propionate—Discomfort—Triamcinolone—multiple sclerosis	8.76e-05	0.00137	CcSEcCtD
Testosterone Propionate—Discomfort—Methylprednisolone—multiple sclerosis	8.74e-05	0.00136	CcSEcCtD
Testosterone Propionate—Headache—Azathioprine—multiple sclerosis	8.73e-05	0.00136	CcSEcCtD
Testosterone Propionate—Angiopathy—Prednisone—multiple sclerosis	8.58e-05	0.00134	CcSEcCtD
Testosterone Propionate—Confusional state—Methylprednisolone—multiple sclerosis	8.55e-05	0.00133	CcSEcCtD
Testosterone Propionate—Immune system disorder—Prednisone—multiple sclerosis	8.54e-05	0.00133	CcSEcCtD
Testosterone Propionate—Malaise—Dexamethasone—multiple sclerosis	8.52e-05	0.00133	CcSEcCtD
Testosterone Propionate—Malaise—Betamethasone—multiple sclerosis	8.52e-05	0.00133	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Triamcinolone—multiple sclerosis	8.5e-05	0.00132	CcSEcCtD
Testosterone Propionate—Oedema—Triamcinolone—multiple sclerosis	8.5e-05	0.00132	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Methylprednisolone—multiple sclerosis	8.48e-05	0.00132	CcSEcCtD
Testosterone Propionate—Haematuria—Methotrexate—multiple sclerosis	8.39e-05	0.00131	CcSEcCtD
Testosterone Propionate—Insomnia—Prednisolone—multiple sclerosis	8.36e-05	0.0013	CcSEcCtD
Testosterone Propionate—Alopecia—Prednisone—multiple sclerosis	8.35e-05	0.0013	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Methotrexate—multiple sclerosis	8.32e-05	0.0013	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Methylprednisolone—multiple sclerosis	8.32e-05	0.0013	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Mitoxantrone—multiple sclerosis	8.3e-05	0.00129	CcSEcCtD
Testosterone Propionate—Paraesthesia—Prednisolone—multiple sclerosis	8.3e-05	0.00129	CcSEcCtD
Testosterone Propionate—Mental disorder—Prednisone—multiple sclerosis	8.28e-05	0.00129	CcSEcCtD
Testosterone Propionate—Nausea—Azathioprine—multiple sclerosis	8.28e-05	0.00129	CcSEcCtD
Testosterone Propionate—Skin disorder—Methylprednisolone—multiple sclerosis	8.24e-05	0.00128	CcSEcCtD
Testosterone Propionate—Malnutrition—Prednisone—multiple sclerosis	8.23e-05	0.00128	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—STAT3—multiple sclerosis	8.17e-05	0.00373	CbGpPWpGaD
Testosterone Propionate—Hypertension—Betamethasone—multiple sclerosis	8.16e-05	0.00127	CcSEcCtD
Testosterone Propionate—Hypertension—Dexamethasone—multiple sclerosis	8.16e-05	0.00127	CcSEcCtD
Testosterone Propionate—Asthenia—Mitoxantrone—multiple sclerosis	8.08e-05	0.00126	CcSEcCtD
Testosterone Propionate—Myalgia—Betamethasone—multiple sclerosis	8.04e-05	0.00125	CcSEcCtD
Testosterone Propionate—Myalgia—Dexamethasone—multiple sclerosis	8.04e-05	0.00125	CcSEcCtD
Testosterone Propionate—Anxiety—Betamethasone—multiple sclerosis	8.02e-05	0.00125	CcSEcCtD
Testosterone Propionate—Anxiety—Dexamethasone—multiple sclerosis	8.02e-05	0.00125	CcSEcCtD
Testosterone Propionate—Discomfort—Dexamethasone—multiple sclerosis	7.95e-05	0.00124	CcSEcCtD
Testosterone Propionate—Discomfort—Betamethasone—multiple sclerosis	7.95e-05	0.00124	CcSEcCtD
Testosterone Propionate—Haemoglobin—Methotrexate—multiple sclerosis	7.94e-05	0.00124	CcSEcCtD
Testosterone Propionate—Pain—Prednisolone—multiple sclerosis	7.9e-05	0.00123	CcSEcCtD
Testosterone Propionate—Haemorrhage—Methotrexate—multiple sclerosis	7.9e-05	0.00123	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	7.9e-05	0.00361	CbGpPWpGaD
Testosterone Propionate—Urinary tract disorder—Methotrexate—multiple sclerosis	7.8e-05	0.00122	CcSEcCtD
Testosterone Propionate—Urethral disorder—Methotrexate—multiple sclerosis	7.74e-05	0.00121	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	7.74e-05	0.00121	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	7.73e-05	0.0012	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Dexamethasone—multiple sclerosis	7.71e-05	0.0012	CcSEcCtD
Testosterone Propionate—Oedema—Betamethasone—multiple sclerosis	7.71e-05	0.0012	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Betamethasone—multiple sclerosis	7.71e-05	0.0012	CcSEcCtD
Testosterone Propionate—Oedema—Dexamethasone—multiple sclerosis	7.71e-05	0.0012	CcSEcCtD
Testosterone Propionate—Diarrhoea—Mitoxantrone—multiple sclerosis	7.71e-05	0.0012	CcSEcCtD
Testosterone Propionate—Insomnia—Triamcinolone—multiple sclerosis	7.69e-05	0.0012	CcSEcCtD
Testosterone Propionate—Insomnia—Methylprednisolone—multiple sclerosis	7.67e-05	0.0012	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Prednisone—multiple sclerosis	7.64e-05	0.00119	CcSEcCtD
Testosterone Propionate—Paraesthesia—Triamcinolone—multiple sclerosis	7.63e-05	0.00119	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Prednisolone—multiple sclerosis	7.62e-05	0.00119	CcSEcCtD
Testosterone Propionate—Paraesthesia—Methylprednisolone—multiple sclerosis	7.61e-05	0.00119	CcSEcCtD
Testosterone Propionate—Dyspnoea—Triamcinolone—multiple sclerosis	7.58e-05	0.00118	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Dexamethasone—multiple sclerosis	7.56e-05	0.00118	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Betamethasone—multiple sclerosis	7.56e-05	0.00118	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	7.46e-05	0.0034	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SRM—multiple sclerosis	7.45e-05	0.0034	CbGpPWpGaD
Testosterone Propionate—Malaise—Prednisone—multiple sclerosis	7.42e-05	0.00116	CcSEcCtD
Testosterone Propionate—Urticaria—Prednisolone—multiple sclerosis	7.34e-05	0.00114	CcSEcCtD
Testosterone Propionate—Fatigue—Triamcinolone—multiple sclerosis	7.33e-05	0.00114	CcSEcCtD
Testosterone Propionate—Fatigue—Methylprednisolone—multiple sclerosis	7.31e-05	0.00114	CcSEcCtD
Testosterone Propionate—Pain—Triamcinolone—multiple sclerosis	7.27e-05	0.00113	CcSEcCtD
Testosterone Propionate—Angiopathy—Methotrexate—multiple sclerosis	7.17e-05	0.00112	CcSEcCtD
Testosterone Propionate—Vomiting—Mitoxantrone—multiple sclerosis	7.16e-05	0.00112	CcSEcCtD
Testosterone Propionate—Immune system disorder—Methotrexate—multiple sclerosis	7.14e-05	0.00111	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—SRM—multiple sclerosis	7.13e-05	0.00325	CbGpPWpGaD
Testosterone Propionate—Mediastinal disorder—Methotrexate—multiple sclerosis	7.12e-05	0.00111	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL10—multiple sclerosis	7.12e-05	0.00325	CbGpPWpGaD
Testosterone Propionate—Hypertension—Prednisone—multiple sclerosis	7.1e-05	0.00111	CcSEcCtD
Testosterone Propionate—Rash—Mitoxantrone—multiple sclerosis	7.1e-05	0.00111	CcSEcCtD
Testosterone Propionate—Dermatitis—Mitoxantrone—multiple sclerosis	7.1e-05	0.00111	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—ZNF746—multiple sclerosis	7.06e-05	0.00322	CbGpPWpGaD
Testosterone Propionate—Headache—Mitoxantrone—multiple sclerosis	7.06e-05	0.0011	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	7.03e-05	0.0011	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	7.03e-05	0.0011	CcSEcCtD
Testosterone Propionate—Arthralgia—Prednisone—multiple sclerosis	7.01e-05	0.00109	CcSEcCtD
Testosterone Propionate—Myalgia—Prednisone—multiple sclerosis	7.01e-05	0.00109	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Triamcinolone—multiple sclerosis	7e-05	0.00109	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Methylprednisolone—multiple sclerosis	6.99e-05	0.00109	CcSEcCtD
Testosterone Propionate—Anxiety—Prednisone—multiple sclerosis	6.98e-05	0.00109	CcSEcCtD
Testosterone Propionate—Alopecia—Methotrexate—multiple sclerosis	6.98e-05	0.00109	CcSEcCtD
Testosterone Propionate—Insomnia—Betamethasone—multiple sclerosis	6.98e-05	0.00109	CcSEcCtD
Testosterone Propionate—Insomnia—Dexamethasone—multiple sclerosis	6.98e-05	0.00109	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	6.96e-05	0.00108	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	6.93e-05	0.00108	CcSEcCtD
Testosterone Propionate—Paraesthesia—Dexamethasone—multiple sclerosis	6.92e-05	0.00108	CcSEcCtD
Testosterone Propionate—Paraesthesia—Betamethasone—multiple sclerosis	6.92e-05	0.00108	CcSEcCtD
Testosterone Propionate—Discomfort—Prednisone—multiple sclerosis	6.92e-05	0.00108	CcSEcCtD
Testosterone Propionate—Mental disorder—Methotrexate—multiple sclerosis	6.92e-05	0.00108	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—POMC—multiple sclerosis	6.9e-05	0.00315	CbGpPWpGaD
Testosterone Propionate—Malnutrition—Methotrexate—multiple sclerosis	6.88e-05	0.00107	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	6.85e-05	0.00313	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Prednisolone—multiple sclerosis	6.81e-05	0.00106	CcSEcCtD
Testosterone Propionate—Urticaria—Triamcinolone—multiple sclerosis	6.75e-05	0.00105	CcSEcCtD
Testosterone Propionate—Urticaria—Methylprednisolone—multiple sclerosis	6.74e-05	0.00105	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Prednisone—multiple sclerosis	6.72e-05	0.00105	CcSEcCtD
Testosterone Propionate—Oedema—Prednisone—multiple sclerosis	6.72e-05	0.00105	CcSEcCtD
Testosterone Propionate—Abdominal pain—Methylprednisolone—multiple sclerosis	6.7e-05	0.00104	CcSEcCtD
Testosterone Propionate—Nausea—Mitoxantrone—multiple sclerosis	6.69e-05	0.00104	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	6.66e-05	0.00104	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Betamethasone—multiple sclerosis	6.66e-05	0.00104	CcSEcCtD
Testosterone Propionate—Fatigue—Dexamethasone—multiple sclerosis	6.65e-05	0.00104	CcSEcCtD
Testosterone Propionate—Fatigue—Betamethasone—multiple sclerosis	6.65e-05	0.00104	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—POMC—multiple sclerosis	6.61e-05	0.00302	CbGpPWpGaD
Testosterone Propionate—Pain—Dexamethasone—multiple sclerosis	6.59e-05	0.00103	CcSEcCtD
Testosterone Propionate—Pain—Betamethasone—multiple sclerosis	6.59e-05	0.00103	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Prednisone—multiple sclerosis	6.59e-05	0.00103	CcSEcCtD
Testosterone Propionate—Skin disorder—Prednisone—multiple sclerosis	6.52e-05	0.00102	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—PTBP1—multiple sclerosis	6.46e-05	0.00295	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	6.39e-05	0.00292	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Methotrexate—multiple sclerosis	6.38e-05	0.000995	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Betamethasone—multiple sclerosis	6.35e-05	0.00099	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Dexamethasone—multiple sclerosis	6.35e-05	0.00099	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	6.34e-05	0.00289	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Betamethasone—multiple sclerosis	6.31e-05	0.000983	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	6.31e-05	0.000983	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Triamcinolone—multiple sclerosis	6.26e-05	0.000976	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Methylprednisolone—multiple sclerosis	6.25e-05	0.000974	CcSEcCtD
Testosterone Propionate—Malaise—Methotrexate—multiple sclerosis	6.2e-05	0.000967	CcSEcCtD
Testosterone Propionate—Urticaria—Betamethasone—multiple sclerosis	6.13e-05	0.000955	CcSEcCtD
Testosterone Propionate—Urticaria—Dexamethasone—multiple sclerosis	6.13e-05	0.000955	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Prednisone—multiple sclerosis	6.12e-05	0.000954	CcSEcCtD
Testosterone Propionate—Dizziness—Prednisolone—multiple sclerosis	6.11e-05	0.000953	CcSEcCtD
Testosterone Propionate—Asthenia—Triamcinolone—multiple sclerosis	6.1e-05	0.00095	CcSEcCtD
Testosterone Propionate—Abdominal pain—Dexamethasone—multiple sclerosis	6.1e-05	0.00095	CcSEcCtD
Testosterone Propionate—Abdominal pain—Betamethasone—multiple sclerosis	6.1e-05	0.00095	CcSEcCtD
Testosterone Propionate—Asthenia—Methylprednisolone—multiple sclerosis	6.08e-05	0.000948	CcSEcCtD
Testosterone Propionate—Insomnia—Prednisone—multiple sclerosis	6.07e-05	0.000947	CcSEcCtD
Testosterone Propionate—Paraesthesia—Prednisone—multiple sclerosis	6.03e-05	0.00094	CcSEcCtD
Testosterone Propionate—Pruritus—Triamcinolone—multiple sclerosis	6.01e-05	0.000937	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—multiple sclerosis	6.01e-05	0.00274	CbGpPWpGaD
Testosterone Propionate—Pruritus—Methylprednisolone—multiple sclerosis	6e-05	0.000935	CcSEcCtD
Testosterone Propionate—Arthralgia—Methotrexate—multiple sclerosis	5.85e-05	0.000913	CcSEcCtD
Testosterone Propionate—Myalgia—Methotrexate—multiple sclerosis	5.85e-05	0.000913	CcSEcCtD
Testosterone Propionate—Rash—Prednisolone—multiple sclerosis	5.83e-05	0.000908	CcSEcCtD
Testosterone Propionate—Dermatitis—Prednisolone—multiple sclerosis	5.82e-05	0.000907	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	5.81e-05	0.000906	CcSEcCtD
Testosterone Propionate—Diarrhoea—Methylprednisolone—multiple sclerosis	5.8e-05	0.000904	CcSEcCtD
Testosterone Propionate—Fatigue—Prednisone—multiple sclerosis	5.79e-05	0.000902	CcSEcCtD
Testosterone Propionate—Headache—Prednisolone—multiple sclerosis	5.79e-05	0.000902	CcSEcCtD
Testosterone Propionate—Discomfort—Methotrexate—multiple sclerosis	5.78e-05	0.000902	CcSEcCtD
Testosterone Propionate—Confusional state—Methotrexate—multiple sclerosis	5.66e-05	0.000882	CcSEcCtD
Testosterone Propionate—Dizziness—Triamcinolone—multiple sclerosis	5.62e-05	0.000876	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Methotrexate—multiple sclerosis	5.61e-05	0.000875	CcSEcCtD
Testosterone Propionate—Dizziness—Methylprednisolone—multiple sclerosis	5.61e-05	0.000874	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Prednisone—multiple sclerosis	5.53e-05	0.000863	CcSEcCtD
Testosterone Propionate—Asthenia—Dexamethasone—multiple sclerosis	5.53e-05	0.000862	CcSEcCtD
Testosterone Propionate—Asthenia—Betamethasone—multiple sclerosis	5.53e-05	0.000862	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Methotrexate—multiple sclerosis	5.5e-05	0.000858	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Prednisone—multiple sclerosis	5.49e-05	0.000856	CcSEcCtD
Testosterone Propionate—Nausea—Prednisolone—multiple sclerosis	5.49e-05	0.000856	CcSEcCtD
Testosterone Propionate—Pruritus—Dexamethasone—multiple sclerosis	5.46e-05	0.00085	CcSEcCtD
Testosterone Propionate—Pruritus—Betamethasone—multiple sclerosis	5.46e-05	0.00085	CcSEcCtD
Testosterone Propionate—Skin disorder—Methotrexate—multiple sclerosis	5.45e-05	0.00085	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	5.43e-05	0.00248	CbGpPWpGaD
Testosterone Propionate—Vomiting—Triamcinolone—multiple sclerosis	5.4e-05	0.000842	CcSEcCtD
Testosterone Propionate—Vomiting—Methylprednisolone—multiple sclerosis	5.39e-05	0.00084	CcSEcCtD
Testosterone Propionate—Rash—Triamcinolone—multiple sclerosis	5.36e-05	0.000835	CcSEcCtD
Testosterone Propionate—Dermatitis—Triamcinolone—multiple sclerosis	5.35e-05	0.000834	CcSEcCtD
Testosterone Propionate—Rash—Methylprednisolone—multiple sclerosis	5.35e-05	0.000833	CcSEcCtD
Testosterone Propionate—Dermatitis—Methylprednisolone—multiple sclerosis	5.34e-05	0.000833	CcSEcCtD
Testosterone Propionate—Urticaria—Prednisone—multiple sclerosis	5.34e-05	0.000832	CcSEcCtD
Testosterone Propionate—Headache—Triamcinolone—multiple sclerosis	5.32e-05	0.00083	CcSEcCtD
Testosterone Propionate—Headache—Methylprednisolone—multiple sclerosis	5.31e-05	0.000828	CcSEcCtD
Testosterone Propionate—Abdominal pain—Prednisone—multiple sclerosis	5.31e-05	0.000827	CcSEcCtD
Testosterone Propionate—Diarrhoea—Betamethasone—multiple sclerosis	5.28e-05	0.000822	CcSEcCtD
Testosterone Propionate—Diarrhoea—Dexamethasone—multiple sclerosis	5.28e-05	0.000822	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—CYP24A1—multiple sclerosis	5.25e-05	0.00239	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP27B1—multiple sclerosis	5.25e-05	0.00239	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	5.11e-05	0.000797	CcSEcCtD
Testosterone Propionate—Dizziness—Betamethasone—multiple sclerosis	5.1e-05	0.000795	CcSEcCtD
Testosterone Propionate—Dizziness—Dexamethasone—multiple sclerosis	5.1e-05	0.000795	CcSEcCtD
Testosterone Propionate—Insomnia—Methotrexate—multiple sclerosis	5.08e-05	0.000791	CcSEcCtD
Testosterone Propionate—Nausea—Triamcinolone—multiple sclerosis	5.05e-05	0.000787	CcSEcCtD
Testosterone Propionate—Paraesthesia—Methotrexate—multiple sclerosis	5.04e-05	0.000786	CcSEcCtD
Testosterone Propionate—Nausea—Methylprednisolone—multiple sclerosis	5.04e-05	0.000785	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—CYP27B1—multiple sclerosis	5.02e-05	0.00229	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP24A1—multiple sclerosis	5.02e-05	0.00229	CbGpPWpGaD
Testosterone Propionate—Dyspnoea—Methotrexate—multiple sclerosis	5e-05	0.00078	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—multiple sclerosis	4.96e-05	0.00226	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Prednisone—multiple sclerosis	4.95e-05	0.000771	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	4.91e-05	0.00224	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.91e-05	0.00224	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—STAT3—multiple sclerosis	4.9e-05	0.00224	CbGpPWpGaD
Testosterone Propionate—Vomiting—Betamethasone—multiple sclerosis	4.9e-05	0.000764	CcSEcCtD
Testosterone Propionate—Vomiting—Dexamethasone—multiple sclerosis	4.9e-05	0.000764	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—HNRNPA1—multiple sclerosis	4.89e-05	0.00223	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—U2AF2—multiple sclerosis	4.89e-05	0.00223	CbGpPWpGaD
Testosterone Propionate—Rash—Betamethasone—multiple sclerosis	4.86e-05	0.000758	CcSEcCtD
Testosterone Propionate—Rash—Dexamethasone—multiple sclerosis	4.86e-05	0.000758	CcSEcCtD
Testosterone Propionate—Dermatitis—Betamethasone—multiple sclerosis	4.86e-05	0.000757	CcSEcCtD
Testosterone Propionate—Dermatitis—Dexamethasone—multiple sclerosis	4.86e-05	0.000757	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Methotrexate—multiple sclerosis	4.85e-05	0.000755	CcSEcCtD
Testosterone Propionate—Fatigue—Methotrexate—multiple sclerosis	4.84e-05	0.000754	CcSEcCtD
Testosterone Propionate—Headache—Dexamethasone—multiple sclerosis	4.83e-05	0.000753	CcSEcCtD
Testosterone Propionate—Headache—Betamethasone—multiple sclerosis	4.83e-05	0.000753	CcSEcCtD
Testosterone Propionate—Asthenia—Prednisone—multiple sclerosis	4.82e-05	0.000751	CcSEcCtD
Testosterone Propionate—Pain—Methotrexate—multiple sclerosis	4.8e-05	0.000748	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—GPC5—multiple sclerosis	4.8e-05	0.00219	CbGpPWpGaD
Testosterone Propionate—Pruritus—Prednisone—multiple sclerosis	4.75e-05	0.000741	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Methotrexate—multiple sclerosis	4.63e-05	0.000721	CcSEcCtD
Testosterone Propionate—Diarrhoea—Prednisone—multiple sclerosis	4.6e-05	0.000716	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—GPC5—multiple sclerosis	4.59e-05	0.0021	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.59e-05	0.000715	CcSEcCtD
Testosterone Propionate—Nausea—Dexamethasone—multiple sclerosis	4.58e-05	0.000714	CcSEcCtD
Testosterone Propionate—Nausea—Betamethasone—multiple sclerosis	4.58e-05	0.000714	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—SRM—multiple sclerosis	4.46e-05	0.00204	CbGpPWpGaD
Testosterone Propionate—Urticaria—Methotrexate—multiple sclerosis	4.46e-05	0.000695	CcSEcCtD
Testosterone Propionate—Dizziness—Prednisone—multiple sclerosis	4.44e-05	0.000692	CcSEcCtD
Testosterone Propionate—Abdominal pain—Methotrexate—multiple sclerosis	4.44e-05	0.000692	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—PGR—multiple sclerosis	4.42e-05	0.00202	CbGpPWpGaD
Testosterone Propionate—Vomiting—Prednisone—multiple sclerosis	4.27e-05	0.000666	CcSEcCtD
Testosterone Propionate—Norethindrone—ALB—multiple sclerosis	4.25e-05	0.014	CrCbGaD
Testosterone Propionate—Rash—Prednisone—multiple sclerosis	4.23e-05	0.00066	CcSEcCtD
Testosterone Propionate—Dermatitis—Prednisone—multiple sclerosis	4.23e-05	0.000659	CcSEcCtD
Testosterone Propionate—Headache—Prednisone—multiple sclerosis	4.21e-05	0.000656	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Methotrexate—multiple sclerosis	4.14e-05	0.000645	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—POMC—multiple sclerosis	4.13e-05	0.00189	CbGpPWpGaD
Testosterone Propionate—Methyltestosterone—ALB—multiple sclerosis	4.04e-05	0.0133	CrCbGaD
Testosterone Propionate—Asthenia—Methotrexate—multiple sclerosis	4.03e-05	0.000628	CcSEcCtD
Testosterone Propionate—Nausea—Prednisone—multiple sclerosis	3.99e-05	0.000622	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—RRM1—multiple sclerosis	3.98e-05	0.00181	CbGpPWpGaD
Testosterone Propionate—Pruritus—Methotrexate—multiple sclerosis	3.97e-05	0.000619	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—ZFP36L1—multiple sclerosis	3.87e-05	0.00177	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Methotrexate—multiple sclerosis	3.84e-05	0.000599	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—RRM1—multiple sclerosis	3.81e-05	0.00174	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	3.73e-05	0.0017	CbGpPWpGaD
Testosterone Propionate—Dizziness—Methotrexate—multiple sclerosis	3.71e-05	0.000578	CcSEcCtD
Testosterone Propionate—Vomiting—Methotrexate—multiple sclerosis	3.57e-05	0.000556	CcSEcCtD
Testosterone Propionate—Rash—Methotrexate—multiple sclerosis	3.54e-05	0.000552	CcSEcCtD
Testosterone Propionate—Dermatitis—Methotrexate—multiple sclerosis	3.54e-05	0.000551	CcSEcCtD
Testosterone Propionate—Headache—Methotrexate—multiple sclerosis	3.52e-05	0.000548	CcSEcCtD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.46e-05	0.00158	CbGpPWpGaD
Testosterone Propionate—Nausea—Methotrexate—multiple sclerosis	3.33e-05	0.00052	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—CYP27B1—multiple sclerosis	3.14e-05	0.00143	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP24A1—multiple sclerosis	3.14e-05	0.00143	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—VDR—multiple sclerosis	3.09e-05	0.00141	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PABPC1—multiple sclerosis	3e-05	0.00137	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	2.99e-05	0.00136	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.95e-05	0.00135	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	2.92e-05	0.00133	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GPC5—multiple sclerosis	2.87e-05	0.00131	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—TGFB1—multiple sclerosis	2.72e-05	0.00124	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—TNF—multiple sclerosis	2.71e-05	0.00124	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—RPL5—multiple sclerosis	2.71e-05	0.00123	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—MAPK1—multiple sclerosis	2.65e-05	0.00121	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.54e-05	0.00116	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.47e-05	0.00113	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.47e-05	0.00113	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.42e-05	0.0011	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—RRM1—multiple sclerosis	2.38e-05	0.00109	CbGpPWpGaD
Testosterone Propionate—Testosterone—ALB—multiple sclerosis	2.34e-05	0.0077	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.31e-05	0.00106	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.3e-05	0.00105	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—BCHE—multiple sclerosis	2.28e-05	0.00104	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—BCHE—multiple sclerosis	2.19e-05	0.000998	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.19e-05	0.000998	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PGR—multiple sclerosis	2.13e-05	0.000972	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—VDR—multiple sclerosis	1.49e-05	0.000679	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—APOE—multiple sclerosis	1.37e-05	0.000627	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—BCHE—multiple sclerosis	1.37e-05	0.000624	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—APOE—multiple sclerosis	1.32e-05	0.0006	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—MYC—multiple sclerosis	1.23e-05	0.000561	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—POMC—multiple sclerosis	1.18e-05	0.000539	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—POMC—multiple sclerosis	1.13e-05	0.000516	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ALB—multiple sclerosis	1.08e-05	0.000491	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ALB—multiple sclerosis	1.03e-05	0.00047	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—APOE—multiple sclerosis	8.23e-06	0.000376	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—POMC—multiple sclerosis	7.07e-06	0.000323	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ALB—multiple sclerosis	6.45e-06	0.000294	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MYC—multiple sclerosis	5.92e-06	0.00027	CbGpPWpGaD
